Top Markets
Coin of the day
Connect Biopharma Holdings Limited Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited

CNTB
주식 순위 #19727
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical... Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.
주가
$2.42
마지막 동기화: 2026-08-25
시가총액
$152.37M
변동 (1일)
5.22%
변동 (1년)
39.88%
국가
US
거래 Connect Biopharma Holdings Limited (CNTB)

카테고리

Connect Biopharma Holdings Limited (CNTB)의 주가 이력
최고 종가: $2.35 (2026-08-01 기준)

최저 종가: $17.02 (2021-03-01 기준)
Connect Biopharma Holdings Limited의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -8.60%
2025 129.78%
2024 18.63%
2023 21.12%
2022 -83.36%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$123.02 -11.98%
AU
$772.27 7.33%
CH